# US 2022/0045286 A1 · Organometallic compound, light-emitting device including the same, and electronic apparatus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0045286 A1
- Document ID: US20220045286A1
- Status: Published application
- Kind: A1
- Application number: 17/384,623
- Filed: 2021-07-23
- Published: 2022-02-10
- Earliest claimed: 2020-07-31
- Assignees: Samsung Display Co., Ltd.
- Applicants: Samsung Display Co., Ltd.
- Inventors: Eunyoung LEE; Soobyung KO; Haejin KIM; Sujin SHIN; Eunsoo AHN; Junghoon HAN
- Web page: https://patentgrep.com/patent/US20220045286A1

## CPC

- C09K 11/06: containing organic luminescent materials
- C07B 59/004: {Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium}
- C07F 15/0086: {Platinum compounds}
- H10K 85/346: {comprising platinum}
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C09K 2211/1062: with oxygen
- C09K 2211/185: of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
- H10K 50/11: characterised by the electroluminescent [EL] layers
- H10K 50/15: Hole transporting layers
- H10K 50/16: Electron transporting layers
- H10K 50/171: {Electron injection layers}
- H10K 50/18: Carrier blocking layers
- H10K 50/858: comprising refractive means, e.g. lenses
- H10K 59/123: Connection of the pixel electrodes to the thin film transistors [TFT]
- H10K 2101/10: Triplet emission
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- H10K: ORGANIC ELECTRIC SOLID-STATE DEVICES

## Abstract

An organometallic compound represented by Formula 1, a light-emitting device including the same, and an electronic apparatus including the light-emitting device are disclosed. In Formula 1, the substituents are as described in more detail in the specification.

## Claims

### Claim 1

A light-emitting device comprising:
a first electrode;
a second electrode facing the first electrode; and
an interlayer between the first electrode and the second electrode and comprising an emission layer,
wherein the interlayer comprises at least one organometallic compound represented by Formula 1:
wherein, in Formula 1,
M1 is selected from platinum (Pt), palladium (Pd), copper (Cu), silver (Ag), gold (Au), rhodium (Rh), iridium (Ir), ruthenium (Ru), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), and thulium (Tm),
Y1 to Y3 are each independently selected from a carbon atom (C) and a nitrogen atom (N),
T1 to T4 are each independently a chemical bond, O, S, B(R′), N(R′), P(R′), C(R′)(R″), Si(R′)(R″), Ge(R′)(R″), or C(═O),
when T1 is a chemical bond, Y1 and M1 are directly bonded to each other,
when T2 is a chemical bond, Y2 and M1 are directly bonded to each other,
when T3 is a chemical bond, Y3 and M1 are directly bonded to each other,
when T4 is a chemical bond, C in ring A4 is directly bonded to M1,
two bonds selected from a bond between M1 and Y1 or T1, a bond between M1 and Y2 or T2, a bond between M1 and Y3 or T3, and a bond between M1 and C in ring A4 or T4 are each a coordinate bond, and the remaining two bonds are each a covalent bond,
ring A1 to ring A3, ring A11 and ring A12 are each independently selected from a C5-C60 carbocyclic group and a C1-C60 heterocyclic group,
L1 to L3 are each independently selected from a single bond, a double bond, *—N(R4)—*′, *—B(R4)—*′, *—P(R4)—*′, *—C(R4)(R5)—*′, *—Si(R4)(R5)—*′, *—Ge(R4)(R5)—*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)—*′, *—S(═O)—*′, *—S(═O)2—*′, *—C(R4)═*′, *═C(R4)—*′, *—C(R4)═C(R5)—*′, *—C(═S)—*′, and *—C≡C—*′,
a1 to a3 are each independently an integer from 0 to 3,
when a1 is 0, ring A1 and ring A2 are not linked to each other,
when a2 is 0, ring A2 and ring A3 are not linked to each other,
when a3 is 0, ring A3 and ring A4 are not linked to each other,
R′, R″, R1 to R5, R11 and R12 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C60 alkyl group unsubstituted or substituted with at least one R10a, a C2-C60 alkenyl group unsubstituted or substituted with at least one R10a, a C2-C60 alkynyl group unsubstituted or substituted with at least one R10a, a C1-C60 alkoxy group unsubstituted or substituted with at least one R10a, a C3-C60 carbocyclic group unsubstituted or substituted with at least one R10a, a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a, a C6-C60 aryloxy group unsubstituted or substituted with at least one R10a, a C6-C60 arylthio group unsubstituted or substituted with at least one R10a, —Si(Q1)(Q2)(Q3), —B(Q1)(Q2), —N(Q1)(Q2), —P(Q1)(Q2), —C(═O)(Qi), —S(═O)(Q1), —S(═O)2(Q1), —P(═O)(Q1)(Q2), and —P(═S)(Q1)(Q2),
b1 to b3, b11 and b12 are each independently an integer from 1 to 20,
two or more neighboring groups from among R1 to R5, R11 and R12 are optionally bonded to form a C5-C60 carbocyclic group unsubstituted or substituted with at least one R10a or a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a,
* and *′ each indicate a binding site to a neighboring atom, and R10a is:
deuterium (-D), —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group;
a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, or a C1-C60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C3-C60 carbocyclic group, a C1-C60 heterocyclic group, a C6-C60 aryloxy group, a C6-C60 arylthio group, —Si(Q11)(Q12)(Q13), —N(Q11)(Q12), —B(Q11)(Q12), —C(═O)(Q11), —S(═O)2(Q11), —P(═O)(Q11)(Q12), or any combination thereof;
a C3-C60 carbocyclic group, a C1-C60 heterocyclic group, a C6-C60 aryloxy group, or a C6-C60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C60 carbocyclic group, a C1-C60 heterocyclic group, a C6-C60 aryloxy group, a C6-C60 arylthio group, —Si(Q21)(Q22)(Q23), —N(Q21)(Q22), —B(Q21)(Q22), —C(═O)(Q21), —S(═O)2(Q21), —P(═O)(Q21)(Q22), or any combination thereof; or
—Si(Q31)(Q32)(Q33), —N(Q31)(Q32), —B(Q31)(Q32), —C(═O)(Q31), —S(═O)2(Q31), or —P(═O)(Q31)(Q32), and
wherein Q1 to Q3, Q11 to Q13, Q21 to Q23, and Q31 to Q33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C1-C60 alkyl group; a C2-C60 alkenyl group; a C2-C60 alkynyl group; a C1-C60 alkoxy group; or a C3-C60 carbocyclic group or a C1-C60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C1-C60 alkyl group, a C1-C60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.

### Claim 2 (depends on 1)

The light-emitting device of claim 1, wherein
the first electrode is an anode,
the second electrode is a cathode,
the interlayer further comprises a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode,
the hole transport region comprises a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and
the electron transport region comprises a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof.

### Claim 3 (depends on 1)

The light-emitting device of claim 1, further comprising a second capping layer on the second electrode,
wherein the second capping layer comprises a material having a refractive index of 1.6 or more at a wavelength of 589 nm.

### Claim 4 (depends on 1)

The light-emitting device of claim 1, wherein the emission layer comprises the at least one organometallic compound.

### Claim 5 (depends on 4)

The light-emitting device of claim 4, wherein the emission layer further comprises a host, and an amount of the at least one organometallic compound is from 0.01 parts by weight to 49.99 parts in amount by weight based on 100 parts by weight of the emission layer.

### Claim 6 (depends on 4)

The light-emitting device of claim 4, wherein the emission layer is to emit green light having a maximum luminescence wavelength of 500 nm to 570 nm.

### Claim 7 (depends on 2)

The light-emitting device of claim 2, wherein the electron transport region comprises a phosphine oxide-containing compound.

### Claim 8 (depends on 1)

An electronic apparatus comprising the light-emitting device of claim 1.

### Claim 9 (depends on 8)

The electronic apparatus of claim 8, further comprising a thin-film transistor,
wherein the thin-film transistor comprises a source electrode and a drain electrode, and
the first electrode of the light-emitting device is electrically connected to the source electrode or the drain electrode of the thin-film transistor.

### Claim 10 (depends on 8)

The electronic apparatus of claim 8, further comprising a color filter, a color conversion layer, a touch screen layer, a polarizing layer, or any combination thereof.

### Claim 11

An organometallic compound represented by Formula 1:
Formula 1
wherein, in Formula 1,
M1 is selected from platinum (Pt), palladium (Pd), copper (Cu), silver (Ag), gold (Au), rhodium (Rh), iridium (Ir), ruthenium (Ru), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), and thulium (Tm),
Y1 to Y3 are each independently selected from a carbon atom (C) and a nitrogen atom (N),
T1 to T4 are each independently a chemical bond, O, S, B(R′), N(R′), P(R′), C(R′)(R″), Si(R′)(R″), Ge(R′)(R″), or C(═O),
when T1 is a chemical bond, Y1 and M1 are directly bonded to each other,
when T2 is a chemical bond, Y2 and M1 are directly bonded to each other,
when T3 is a chemical bond, Y3 and M1 are directly bonded to each other,
when T4 is a chemical bond, C in ring A4 is directly bonded to M1,
two bonds selected from a bond between M1 and Y1 or T1, a bond between M1 and Y2 or T2, a bond between M1 and Y3 or T3, and a bond between M1 and C in ring A4 or T4 are each a coordinate bond, and the remaining two bonds are each a covalent bond,
ring A1 to ring A3, ring A11 and ring A12 are each independently selected from a C5-C60 carbocyclic group and a C1-C60 heterocyclic group,
L1 to L3 are each independently selected from a single bond, a double bond, *—N(R4)—*′, *—B(R4)—*′, *—P(R4)—*′, *—C(R4)(R5)—*′, *—Si(R4)(R5)—*′, *—Ge(R4)(R5)—*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)—*′, *—S(═O)—*′, *—S(═O)2—*′, *—C(R4)═*′, *═C(R4)—*′, *—C(R4)═C(R5)—*′, *—C(═S)—*′, and *—C≡C—*′,
a1 to a3 are each independently an integer from 0 to 3,
when a1 is 0, ring A1 and ring A2 are not linked to each other,
when a2 is 0, ring A2 and ring A3 are not linked to each other,
when a3 is 0, ring A3 and ring A4 are not linked to each other,
R′, R″, R1 to R5, R11 and R12 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C60 alkyl group unsubstituted or substituted with at least one R10a, a C2-C60 alkenyl group unsubstituted or substituted with at least one R10a, a C2-C60 alkynyl group unsubstituted or substituted with at least one R10a, a C1-C60 alkoxy group unsubstituted or substituted with at least one R10a, a C3-C60 carbocyclic group unsubstituted or substituted with at least one R10a, a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a, a C6-C60 aryloxy group unsubstituted or substituted with at least one R10a, a C6-C60 arylthio group unsubstituted or substituted with at least one R10a, —Si(Q1)(Q2)(Q3), —B(Q1)(Q2), —N(Q1)(Q2), —P(Q1)(Q2), —C(═O)(Qi), —S(═O)(Qi), —S(═O)2(Qi), —P(═O)(Qi)(Q2), and —P(═S)(Q1)(Q2),
b1 to b3, b11 and b12 are each independently an integer from 1 to 20,
two or more neighboring groups from among R1 to R5, R11 and R12 are optionally bonded to form a C5-C60 carbocyclic group unsubstituted or substituted with at least one R10a or a C1-C60 heterocyclic group unsubstituted or substituted with at least one R10a,
* and *′ each indicate a binding site to a neighboring atom, and
R10a is:
deuterium (-D), —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group;
a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, or a C1-C60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C3-C60 carbocyclic group, a C1-C60 heterocyclic group, a C6-C60 aryloxy group, a C6-C60 arylthio group, —Si(Q11)(Q12)(Q13), —N(Q11)(Q12), —B(Q11)(Q12), —C(═O)(Q11), —S(═O)2(Q11), —P(═O)(Q11)(Q12), or any combination thereof;
a C3-C60 carbocyclic group, a C1-C60 heterocyclic group, a C6-C60 aryloxy group, or a C6-C60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C60 carbocyclic group, a C1-C60 heterocyclic group, a C6-C60 aryloxy group, a C6-C60 arylthio group, —Si(Q21)(Q22)(Q23), —N(Q21)(Q22), —B(Q21)(Q22), —C(═O)(Q21), —S(═O)2(Q21), —P(═O)(Q21)(Q22), or any combination thereof; or
—Si(Q31)(Q32)(Q33), —N(Q31)(Q32), —B(Q31)(Q32), —C(═O)(Q31), —S(═O)2(Q31), or —P(═O)(Q31)(Q32), and
wherein Q1 to Q3, Q11 to Q13, Q21 to Q23, and Q31 to Q33 are each independently:
hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C1-C60 alkyl group; a C2-C60 alkenyl group; a C2-C60 alkynyl group; a C1-C60 alkoxy group; or a C3-C60 carbocyclic group or a C1-C60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C1-C60 alkyl group, a C1-C60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.

### Claim 12 (depends on 11)

The organometallic compound of claim 11, wherein M1 is selected from Pt, Pd, Cu, Ag, Au, Rh, Ir, Ru, and Os.

### Claim 13 (depends on 11)

The organometallic compound of claim 11, wherein Y1 is N, and Y2 and Y3 are each C.

### Claim 14 (depends on 11)

The organometallic compound of claim 11, wherein ring A1 to ring A3, ring A11 and ring A12 are each independently selected from a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentane group, a cyclopentadiene group, a cyclohexane group, a cyclohexene group, a 1,2,3,4-tetrahydronaphthalene group, a furan group, a thiophene group, a silole group, an indene group, a fluorene group, an indole group, a carbazole group, a benzofuran group, a dibenzofuran group, a benzothiophene group, a dibenzothiophene group, a benzosilole group, a dibenzosilole group, an indenopyridine group, an indolopyridine group, a benzofuropyridine group, a benzothienopyridine group, a benzosilolopyridine group, an indenopyrimidine group, an indolopyrimidine group, a benzofuropyrimidine group, a benzothienopyrimidine group, a benzosilolopyrimidine group, a dihydropyridine group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a 2,3-dihydroimidazole group, a triazole group, a 1,2,4-triazole group, a tetrazole group, a 2,3-dihydrotriazole group, an azasilole group, a diazasilole group, a triazasilole group, an oxazole group, an isooxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a 2,3-dihydrobenzim idazole group, an imidazopyridine group, a 2,3-dihydroimidazopyridine group, an imidazopyrimidine group, a 2,3-dihydroimidazopyrimidine group, an imidazopyrazine group, a 2,3-dihydroimidazopyrazine group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, and a 5,6,7,8-tetrahydroquinoline group.

### Claim 15 (depends on 11)

The organometallic compound of claim 11, wherein at least one of ring A1 to ring A3 is a 6-membered ring having one or more N(s) or a condensed cyclic group comprising the 6-membered ring having one or more N(s).

### Claim 16 (depends on 11)

The organometallic compound of claim 11, wherein
ia) ring A1 is a group represented by one of Formulae 2A-1 to 2A-6,
iia) ring A2 is a group represented by one of Formulae 2B-1 to 2B-3,
iiia) ring A3 is a group represented by Formula 2C-1, or
any combination of ia), iia), and iiia):
wherein, in Formulae 2A-1 to 2A-6, Formulae 2B-1 to 2B-3, and Formula 2C-1,
Y21 is N or C(R21a), Y22 is N or C(R22a), Y23 is N or C(R23a), Y24 is N or C(R24a), Y25 is N or C(R25a), Y26 is N or C(R26a), Y27 is N or C(R27a), and Y28 is N or C(R28a),
Z21 is *′—C, C(R21a) or N, and Z22 is *′—C, C(R22a), or N,
Z31 is *′—N or N(R31a),
R21a to R28a and R31a are the same as described in connection with R′, R″, R1 to R5, R11 and R12 of Formula 1, and
* indicates a binding site to respective neighboring T1, T2, or T3, and *′ indicates a binding site to respective neighboring L1, L2, or L3.

### Claim 17 (depends on 11)

The organometallic compound of claim 11, wherein a group represented by
in Formula 1 is represented by one of Formulae 2D-1 and 2D-2:
wherein, in Formulae 2D-1 and 2D-2,
is N or C(R11a), Y12 is N or C(R12a), Y13 is N or C(R13a), Y14 is N or C(R14a), Y15 is N or C(R15a), Y16 is N or C(R16a), Y17 is N or C(R17a), Y18 is N or C(R18a), and Y19 is N or C(R19a),
R11a to R19a are the same as described in connection with R′, R″, R1 to R5, R11 and R12 in of Formula 1, and
* indicates a binding site to neighboring T4, and *1 indicates a binding site to neighboring L3.

### Claim 18 (depends on 11)

The organometallic compound of claim 11, wherein R′, R″, R1 to R5, R11 and R12 are each independently selected from:
hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C20 alkyl group, and a C1-C20 alkoxy group;
a C1-C20 alkyl group and a C1-C20 alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C20 alkyl group, and a C1-C20 alkoxy group;
a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a pyrrolyl group, an indolyl group, an isoindolyl group, an indazolyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, and a triazinyl group;
a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, and a triazinyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a triazinyl group, —Si(Q31)(Q32)(Q33), —N(Q31)(Q32), —B(Q31)(Q32), —C(═O)(Q31), —S(═O)2(Q31), and —P(═O)(Q31)(Q32);
a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, and a triazinyl group, each substituted with at least one selected from a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, and a triazinyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a triazinyl group, —Si(Q31)(Q32)(Q33), —N(Q31)(Q32), —B(Q31)(Q32), —C(═O)(Q31), —S(═O)2(Q31), and —P(═O)(Q31)(Q32); and
—Si(Q1)(Q2)(Q3), —N(Q1)(Q2), —B(Q1)(Q2), —C(═O)(Qi), —S(═O)2(Q1), —P(═O)(Q1)(Q2), —P(═S)(Q1)(Q2), ═O, ═S, ═N(Q1), and ═C(Q1)(Q2), and
wherein Q1 to Q3 and Q31 to Q33 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a cyano group, a C1-C20 alkyl group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C1-C20 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C20 aryl group, a C1-C20 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.

### Claim 19 (depends on 11)

The organometallic compound of claim 11, wherein the organometallic compound is represented by Formula 1-1:
wherein, in Formula 1-1,
M1, ring A1, ring A3, ring A11, ring A12, Y1 to Y3, L1 to L3, R1, R3, R11, R12, b1, b3, b11, and b12 are each independently the same as respectively described in connection with Formula 1,
ring A21 and ring A22 are each independently the same as described in connection with ring A1 to ring A3, ring A11 and ring A12 of Formula 1, R21 and R22 are each independently the same as described in connection with R′, R″, R1 to R5, R11 and R12 of Formula 1, and
b21 and b22 are each independently the same as described in connection with b1 to b3, b11 and b12 of Formula 1.

### Claim 20 (depends on 11)

The organometallic compound of claim 11, wherein the organometallic compound represented by Formula 1 is one or more selected from Compounds 1 to 131:
